Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY) shares gapped up prior to trading on Tuesday . The stock had previously closed at $4.12, but opened at $4.2725. Hypermarcas shares last traded at $4.35, with a volume of 234 shares traded.

Analysts Set New Price Targets

Separately, Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Hypermarcas has a consensus rating of “Buy”.

Hypermarcas Price Performance

The stock’s 50 day simple moving average is $4.12 and its two-hundred day simple moving average is $4.29. The company has a market capitalization of $3.01 billion, a P/E ratio of 8.54 and a beta of 0.70.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 14.63%. As a group, equities research analysts expect that Hypermarcas will post 0.53 earnings per share for the current year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.